메뉴 건너뛰기




Volumn 40, Issue 4, 2012, Pages 367-371

Serum levels of daptomycin in pediatric patients

Author keywords

Daptomycin; Infants; Neonates; Pediatric patients; Serum concentrations

Indexed keywords

DAPTOMYCIN; GENTAMICIN; LINEZOLID; RIFAMPICIN; VANCOMYCIN;

EID: 84866647887     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-011-0240-3     Document Type: Article
Times cited : (36)

References (14)
  • 2
    • 75749105024 scopus 로고    scopus 로고
    • Daptomycin: From the mountain to the clinic, with essential help from Francis Tally, MD
    • Eisenstein BI, Oleson FB Jr, Baltz RH. Daptomycin: from the mountain to the clinic, with essential help from Francis Tally, MD. Clin Infect Dis. 2010;50:S10-5.
    • (2010) Clin Infect Dis. , vol.50
    • Eisenstein, B.I.1    Oleson Jr., F.B.2    Baltz, R.H.3
  • 3
    • 0037378761 scopus 로고    scopus 로고
    • Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects
    • Dvorchik BH, Brazier D, DeBruin MF, Arbeit RD. Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects. Antimicrob Agents Chemother. 2003;47:1318-23.
    • (2003) Antimicrob Agents Chemother. , vol.47 , pp. 1318-1323
    • Dvorchik, B.H.1    Brazier, D.2    DeBruin, M.F.3    Arbeit, R.D.4
  • 4
    • 33749534709 scopus 로고    scopus 로고
    • Pharma-cokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers
    • Benvenuto M, Benziger DP, Yankelev S, Vigliani G. Pharma-cokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers. Antimicrob Agents Chemother. 2006;50:3245-9.
    • (2006) Antimicrob Agents Chemother. , vol.50 , pp. 3245-3249
    • Benvenuto, M.1    Benziger, D.P.2    Yankelev, S.3    Vigliani, G.4
  • 7
    • 79960619126 scopus 로고    scopus 로고
    • Single-dose pharmacokinetics and tolera-bility of daptomycin 8-10 mg/kg in children aged 2-6 years with suspected or proved Gram-Positive infections
    • Abdel-Rahman SM, Chandorkar G, Akins RL, Bradley JS, Jacobs RF, Donovan J, et al. Single-dose pharmacokinetics and tolera-bility of daptomycin 8-10 mg/kg in children aged 2-6 years with suspected or proved Gram-Positive infections. Pediatr Infect Dis J. 2011;30(8):712-4.
    • (2011) Pediatr Infect Dis J. , vol.30 , Issue.8 , pp. 712-714
    • Abdel-Rahman, S.M.1    Chandorkar, G.2    Akins, R.L.3    Bradley, J.S.4    Jacobs, R.F.5    Donovan, J.6
  • 10
    • 67249136858 scopus 로고    scopus 로고
    • Comparison of the pharmacokinetics, safety and tolerability of daptomycin in healthy adult volunteers following intravenous administration by 30 min infusion or 2 min injection
    • Chakraborty A, Roy S, Loeffler J, Chaves RL. Comparison of the pharmacokinetics, safety and tolerability of daptomycin in healthy adult volunteers following intravenous administration by 30 min infusion or 2 min injection. J Antimicrob Chemother. 2009;64:151-8.
    • (2009) J Antimicrob Chemother. , vol.64 , pp. 151-158
    • Chakraborty, A.1    Roy, S.2    Loeffler, J.3    Chaves, R.L.4
  • 11
    • 79951637480 scopus 로고    scopus 로고
    • Tips and traps analyzing pediatric PK data
    • Anderson BJ, Holford NH. Tips and traps analyzing pediatric PK data. Paediatr Anaesth. 2011;21:222-37.
    • (2011) Paediatr Anaesth. , vol.21 , pp. 222-237
    • Anderson, B.J.1    Holford, N.H.2
  • 12
    • 0027311286 scopus 로고
    • Aminoglycoside volume of distribution and illness severity in critically ill septic patients
    • Marik PE. Aminoglycoside volume of distribution and illness severity in critically ill septic patients. Anaesth Intensive Care. 1993;21:172-3.
    • (1993) Anaesth Intensive Care. , vol.21 , pp. 172-173
    • Marik, P.E.1
  • 13
    • 84855244376 scopus 로고    scopus 로고
    • Physiological changes in the critically ill patient with sepsis
    • Epub ahead of print
    • Hosein S, Udy AA, Lipman J. Physiological changes in the critically ill patient with sepsis. Curr Pharm Biotechnol [Epub ahead of print]. 2011.
    • (2011) Curr Pharm Biotechnol
    • Hosein, S.1    Udy, A.A.2    Lipman, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.